Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enteral Nutrition | 3 | 2015 | 16 | 1.570 |
Why?
|
| Intensive Care Units | 6 | 2015 | 57 | 1.350 |
Why?
|
| Critical Illness | 6 | 2015 | 37 | 1.280 |
Why?
|
| Parenteral Nutrition | 3 | 2015 | 11 | 1.210 |
Why?
|
| Sepsis | 3 | 2015 | 76 | 1.100 |
Why?
|
| Critical Care | 3 | 2015 | 37 | 0.640 |
Why?
|
| Acute Lung Injury | 3 | 2011 | 5 | 0.570 |
Why?
|
| Wounds and Injuries | 3 | 2014 | 166 | 0.530 |
Why?
|
| Pulmonary Edema | 4 | 2009 | 7 | 0.510 |
Why?
|
| Pulmonary Alveoli | 4 | 2009 | 26 | 0.490 |
Why?
|
| Designer Drugs | 1 | 2013 | 2 | 0.480 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 165 | 0.400 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 336 | 0.380 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 94 | 0.370 |
Why?
|
| Mental Disorders | 1 | 2013 | 285 | 0.360 |
Why?
|
| Subclavian Vein | 1 | 2007 | 2 | 0.320 |
Why?
|
| Chylothorax | 1 | 2007 | 2 | 0.320 |
Why?
|
| Pleura | 1 | 2007 | 5 | 0.320 |
Why?
|
| Drainage | 1 | 2007 | 11 | 0.320 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2007 | 5 | 0.320 |
Why?
|
| Splenosis | 1 | 2007 | 2 | 0.310 |
Why?
|
| Airway Obstruction | 1 | 2007 | 9 | 0.310 |
Why?
|
| Lung Transplantation | 1 | 2007 | 19 | 0.310 |
Why?
|
| Respiratory Mechanics | 1 | 2007 | 26 | 0.300 |
Why?
|
| Glucocorticoids | 1 | 2007 | 80 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 2 | 2005 | 169 | 0.290 |
Why?
|
| Humans | 25 | 2022 | 34853 | 0.290 |
Why?
|
| Postoperative Complications | 1 | 2007 | 206 | 0.280 |
Why?
|
| Pneumothorax | 1 | 2005 | 9 | 0.280 |
Why?
|
| Hospital Mortality | 2 | 2015 | 183 | 0.230 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 49 | 0.190 |
Why?
|
| Exercise Test | 1 | 2020 | 68 | 0.180 |
Why?
|
| Walking | 1 | 2020 | 64 | 0.180 |
Why?
|
| Middle Aged | 11 | 2020 | 9642 | 0.170 |
Why?
|
| Adult | 10 | 2022 | 11034 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 292 | 0.160 |
Why?
|
| Blood Proteins | 2 | 2009 | 65 | 0.160 |
Why?
|
| Male | 11 | 2020 | 18870 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 27 | 0.130 |
Why?
|
| Glutamine | 1 | 2015 | 31 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2015 | 36 | 0.130 |
Why?
|
| Arginine | 1 | 2015 | 62 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 424 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2010 | 1961 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2015 | 114 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 233 | 0.120 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hallucinations | 1 | 2013 | 6 | 0.120 |
Why?
|
| Benzodiazepines | 1 | 2013 | 13 | 0.120 |
Why?
|
| Poisoning | 1 | 2013 | 11 | 0.120 |
Why?
|
| Female | 10 | 2020 | 19873 | 0.120 |
Why?
|
| Respiration, Artificial | 2 | 2010 | 37 | 0.120 |
Why?
|
| Respiratory Mucosa | 3 | 2009 | 38 | 0.110 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 106 | 0.110 |
Why?
|
| Receptors, Immunologic | 2 | 2010 | 59 | 0.110 |
Why?
|
| Aggression | 1 | 2013 | 75 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2012 | 31 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2021 | 1353 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 555 | 0.100 |
Why?
|
| Aspirin | 1 | 2011 | 45 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2022 | 1349 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2011 | 60 | 0.100 |
Why?
|
| Angiopoietin-2 | 1 | 2010 | 5 | 0.100 |
Why?
|
| Collagen Type III | 1 | 2010 | 7 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 77 | 0.100 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 23 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2010 | 17 | 0.090 |
Why?
|
| Vitamins | 1 | 2011 | 91 | 0.090 |
Why?
|
| Adolescent | 3 | 2020 | 5035 | 0.090 |
Why?
|
| Causality | 1 | 2010 | 45 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2010 | 38 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2010 | 59 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1056 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2010 | 69 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2009 | 7 | 0.090 |
Why?
|
| Blood Coagulation Factors | 1 | 2009 | 5 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 355 | 0.090 |
Why?
|
| Venous Pressure | 1 | 2009 | 1 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 1681 | 0.090 |
Why?
|
| Uteroglobin | 1 | 2009 | 7 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2020 | 1422 | 0.090 |
Why?
|
| Length of Stay | 1 | 2010 | 184 | 0.090 |
Why?
|
| Vitamin D | 1 | 2011 | 176 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 570 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 325 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 77 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 88 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 608 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 14 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2007 | 27 | 0.080 |
Why?
|
| Hydrostatic Pressure | 1 | 2007 | 6 | 0.080 |
Why?
|
| Edema | 1 | 2007 | 20 | 0.080 |
Why?
|
| Inhalation | 1 | 2007 | 8 | 0.080 |
Why?
|
| Extracellular Fluid | 1 | 2007 | 13 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2007 | 30 | 0.080 |
Why?
|
| Logistic Models | 1 | 2010 | 894 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 211 | 0.070 |
Why?
|
| Spleen | 1 | 2007 | 192 | 0.070 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2005 | 3 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2005 | 86 | 0.070 |
Why?
|
| Reference Values | 2 | 2020 | 204 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 984 | 0.060 |
Why?
|
| APACHE | 2 | 2014 | 6 | 0.060 |
Why?
|
| Aged | 5 | 2011 | 6448 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 252 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 206 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 370 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 429 | 0.040 |
Why?
|
| Heart Rate | 1 | 2020 | 248 | 0.040 |
Why?
|
| Mass Screening | 1 | 2021 | 427 | 0.040 |
Why?
|
| Neoplasms | 1 | 2007 | 1033 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2015 | 34 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 1425 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 2009 | 366 | 0.030 |
Why?
|
| United States | 2 | 2015 | 3894 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2012 | 29 | 0.030 |
Why?
|
| Acute Disease | 1 | 2012 | 141 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2011 | 55 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2011 | 71 | 0.020 |
Why?
|
| Testosterone | 1 | 2011 | 181 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4012 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2009 | 5 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 244 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 67 | 0.020 |
Why?
|
| Body Fluids | 1 | 2009 | 15 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 72 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 138 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 8 | 0.020 |
Why?
|
| Diastole | 1 | 2009 | 46 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2009 | 48 | 0.020 |
Why?
|
| Pneumonia | 1 | 2009 | 50 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 37 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 75 | 0.020 |
Why?
|
| Oxygen | 1 | 2009 | 193 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 859 | 0.020 |
Why?
|
| Ion Transport | 1 | 2007 | 15 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 445 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 175 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 707 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 727 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2561 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 435 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 968 | 0.010 |
Why?
|